Liposome Drug Delivery Market – Trends Forecast Till 2030

1
Liposome Drug Delivery Market Navigating Trends
and Forecasts Through 2030
sales_at_delvens.com www.delvens.com
2
Liposome Drug Delivery Market Trends Forecast
Till 2030
Liposome Drug Delivery Market by Product
(Liposomal Doxorubicin, Liposomal Paclitaxel,
Liposomal Amphotericin B, Others) Technology
(Stealth Liposome Technology, Non-PEGylated
Liposome Technology, DepoFoam Liposome
Technology, Lysolipid Thermally Sensitive
Liposome (LTSL)) Application (Fungal Diseases,
Cancer Therapy, Pain Management, Viral Vaccines,
Photodynamic Therapy) and region (North America,
Europe, Asia-Pacific, Middle East and Africa and
South America).
Get a Sample Copy of the Liposome Drug Delivery
Market Research Report (Use Corporate Email ID to
Get Higher Priority) https//www.delvens.com/get-
free-sample/liposome-drug-delivery-market
sales_at_delvens.com
www.delvens.com
3
Market Overview
The global Liposome Drug Delivery Market size is
projected to reach a CAGR of 9.8 from
2023-2030. Liposome drug delivery is a way of
administering a medication that increases its
bioavailability and reduces toxicity. Liposomes
are tiny vesicles made from naturally occurring
molecules in the body, which can transport drugs
into targeted cells for improved effectiveness
while reducing side effects compared to
conventional methods like intravenous injections
or oral medications. The Liposome-mediated drug
delivery technology is one of the most promising
approaches to treating cancers and other
diseases. The growth of the market can be
attributed to the rising prevalence of cancer,
and therefore the need for advanced drug delivery
systems for the treatment of the disease. the
rising focus of healthcare researchers on
developing targeted drug delivery systems (TDDS)
is also expected to create numerous opportunities
for market growth. Furthermore, the factors that
will enhance the growth of the market are the
Growing geriatric population base across the
world, high unmet medical needs owing to the
increasing number of drug-resistant diseases, and
increased use of liposomes for therapeutic
purposes due to their advantages over other
delivery systems such as injection, oral pill
formulations.
sales_at_delvens.com
www.delvens.com
4
Market Overview
On the other hand, High production cost is the
major reason behind the hindrance of market
growth. Additionally, low solubility and short
half-life of liposomes can negatively affect the
preference rate, hindering the growth of the
Liposomes Drug Delivery Market.
An increase has been witnessed in the demand for
medical supplies to take care of the infected
population. Respiratory support devices such as
atomizers, life support machines, oxygen
generators, and monitors are among the majorly
used medical devices in primary clinical
treatment. Moreover, COVID-19 has led to a huge
surge in demand for medical supplies such as
personal protective equipment including masks,
gloves, and protective eyeglasses. The need for
medical supplies has increased significantly
among both healthcare professionals and the civil
population for precautionary measures, owing to
the rise in the number of COVID-19 cases
worldwide. Manufacturers of these products have a
chance to capitalize on this increased demand for
medical supplies to ensure an adequate and
continuous supply of personal protective
equipment in the market. Therefore, COVID-19 is
expected to have a significant impact on the
global liposome drug delivery market.
sales_at_delvens.com
www.delvens.com
5
Delvens Industry Expert's Standpoint
In the upcoming years, the desire for targeted
drug delivery, the prevalence of chronic
illnesses, and developments in liposome
technology are projected to generate a large
increase in the market for liposome drug
delivery. Although there are many businesses
operating in the industry, which is extremely
fragmented, it is also fiercely competitive, with
a few significant firms controlling the majority
of the market share. The market is anticipated to
be dominated by North America and Europe, but the
Asia-Pacific region is anticipated to have
considerable growth because of increased
healthcare spending and the prevalence of chronic
illnesses there. Johnson Johnson, Pfizer, Inc.,
Gilead Sciences, Inc., Teva Pharmaceutical
Industries Ltd., and Sun Pharmaceutical
Industries Ltd. are a few of the market's top
competitors. In the upcoming years, consolidation
is predicted to continue as bigger competitors
buy smaller rivals to broaden their product lines
and boost their market share.
Inquiry Before Buying https//www.delvens.com/Inq
uire-before-buying/liposome-drug-delivery-market
sales_at_delvens.com
www.delvens.com
6
Competitive Landscape

• Johnson and Johnson
• Gilead Sciences
• Pacira
• Sun Pharmaceutical
• Luye Pharma
• Sigma-Tau Group
• Fudan-Zhangjiang
• Teva Pharmaceutical
• CSPC
• Novartis
• Kingond Pharm
• Spectrum Pharmaceuticals
• Shanghai New Asia

sales_at_delvens.com
www.delvens.com
7
Recent Developments

• June 17th, 2020 Ipsen Pharma announced that it
  has received the Fast Track designation by the
  United States Food and Drug Administration (FDA)
  for the investigational use of liposomal
  irinotecan (ONIVYDE) in combination with
  oxaliplatin (OX) and 5-fluorouracil/leucovorin
  (5-FU/LV) together.
• December 9th, 2019 FUJIFILM Toyama Chemical Co.,
  Ltd. announced that it has completed its first
  manufacturing facility named 701 for liposome
  formulation in Japan.

Read More About the Liposome Drug Delivery Market
Research Report https//www.delvens.com/report/li
posome-drug-delivery-market
sales_at_delvens.com
www.delvens.com
8
Reasons to Acquire

• Increase your understanding of the market for
  identifying the best and suitable strategies and
  decisions on the basis of sales or revenue
  fluctuations in terms of volume and value,
  distribution chain analysis, market trends and
  factors.
• Gain authentic and granular data access for
  Liposome Drug Delivery Market so as to understand
  the trends and the factors involved behind
  changing market situations.
• Qualitative and quantitative data utilization to
  discover arrays of future growth from the market
  trends of leaders to market visionaries and then
  recognize the significant areas to compete in the
  future.
• In-depth analysis of the changing trends of the
  market by visualizing the historic and forecast
  year growth patterns.

Direct Purchase of Liposome Drug Delivery Market
Report Research Report https//www.delvens.com/ch
eckout/liposome-drug-delivery-market
sales_at_delvens.com
www.delvens.com
9
Contact Information
About Us Delvens is a strategic advisory and
consulting company headquartered in New Delhi,
India. The company holds expertise in providing
syndicated research reports, customized research
reports and consulting services. Delvens
qualitative and quantitative data is highly
utilized by each level from niche to major
markets, serving more than 1K prominent companies
by assuring to provide the information on
country, regional and global business
environment. We have a database for more than 45
industries in more than 115 major countries
globally. Contact Us 44-20-8638-5055 sales_at_delv
ens.com WEBSITE https//delvens.com/
sales_at_delvens.com
www.delvens.com